Menu UF Health Home Menu

Recent data suggest alternative mechanisms that promote HLA-associated drug syndromes.

Abacavir binds within the antigen-binding cleft of human leukocyte antigen (HLA)-B*57:01. Read more about it here.

Read More
ostrov rock

Molecular Mountaineers

UF drug development researchers are forging new trails to cancer treatments. Read about it here.

Read More

Drug Discovery

We use methods in structure-based drug design to discover and develop novel therapies for human diseases. We are actively targeting cardiovascular diseases, cancer and diabetes by high-throughput virtual screening combined […]

Read More
Prev Next

Contact Us

Nature ImmunologySubscribe to this RSS Feed

XBP1, a determinant of the eosinophil lineage

July 21, 2015

Targeted deletion of the transcription factor XBP1 in hematopoietic stem cells selectively prevents eosinophil maturation in the bone marrow without affecting other lineages of the immune system.

Tuning up FALCs: immunological shielding in the body cavities

July 21, 2015

Fat-associated lymphoid clusters (FALCs) are non-classical secondary lymphoid organs of the body cavities. The formation and maturation of FALCs are driven by tumor-necrosis factor and are further...

DPP4 in anti-tumor immunity: going beyond the enzyme

July 21, 2015

Effective anti-tumor immune therapy in solid tumors relies on the presence of effector T cells. Inhibition of the dipeptidylpeptidase DPP4 (CD26) enhances chemokine CXCL10–mediated infiltration of...

NLRP3 moonlights in TH2 polarization

July 21, 2015

As the cytosolic guardian for many microbial and sterile inflammatory insults, NLRP3 is best appreciated for its innate immunological role mediating inflammasome activation. Now NLRP3 debuts as a...